and other data for a number of reasons, such as keeping FT Sites reliable and secure,
personalising content and ads, providing social media features and to
analyse how our Sites are used.
Add this topic to your myFT Digest for news straight to your inbox
Noubar Afeyan says court rulings on abortion pills and access to healthcare undermine efforts to combat diseases
The chair of the $60bn US biopharma group explains how his approach to combining science with entrepreneurship led to the company’s creation
Top finance director ousted after one day in job following emergence of probe at former employer